These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3834071)

  • 61. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL; Langley MS; Robinson PA; Nummi S; Lund L
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone.
    Meulenberg PM; Hofman JA
    Clin Chim Acta; 1990 Oct; 190(3):211-21. PubMed ID: 2253401
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).
    Cahill M; Mistry R; Chapman C; Wood JK; Barnett DB
    Br J Clin Pharmacol; 1992 Jan; 33(1):11-5. PubMed ID: 1540480
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
    Kendall MJ; Jack DB; Quarterman CP; Smith SR; Zaman R
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):87S-89S. PubMed ID: 6146344
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
    Belsey EM; d'Arcangues C; Carlson N
    Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of high doses of vitamin C on the bioavailability and the serum protein binding of levonorgestrel in women using a combination oral contraceptive.
    Kuhnz W; Louton T; Hümpel M; Back DJ; Zamah NM
    Contraception; 1995 Feb; 51(2):111-6. PubMed ID: 7750288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
    Inauen W; Stocker G; Haeberli A; Straub PW
    Contraception; 1991 May; 43(5):435-46. PubMed ID: 1833126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lack of impairment of fluocortolone disposition in oral contraceptive users.
    Legler UF
    Eur J Clin Pharmacol; 1988; 35(1):101-3. PubMed ID: 3220090
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive.
    Tefany FJ; Georgouras K
    Australas J Dermatol; 1991; 32(1):55-9. PubMed ID: 1834046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ABH blood group antigens during pregnancy and in women on hormonal contraceptives.
    Dalal RM; Sathe MS; Bhatia HM
    Indian J Med Res; 1982 Aug; 76():201-6. PubMed ID: 7174011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J
    Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics.
    Holazo AA; Winkler MB; Patel IH
    J Clin Pharmacol; 1988 Nov; 28(11):1040-5. PubMed ID: 3243917
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.